These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11701684)

  • 1. The relationship between serum GH and serum IGF-I in acromegaly is gender-specific.
    Parkinson C; Ryder WD; Trainer PJ;
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5240-4. PubMed ID: 11701684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender and age influence the relationship between serum GH and IGF-I in patients with acromegaly.
    Parkinson C; Renehan AG; Ryder WD; O'Dwyer ST; Shalet SM; Trainer PJ
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):59-64. PubMed ID: 12100070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
    Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
    J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GH sensitivity of GH-deficient adults is dependent on gender but not timing of onset.
    Columb B; Smethurst LE; Mukherjee A; Jostel A; Shalet SM; Murray RD
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):281-6. PubMed ID: 18702681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly.
    Jenkins PJ; Bates P; Carson MN; Stewart PM; Wass JA
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1239-45. PubMed ID: 16403824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects.
    Hilding A; Hall K; Wivall-Helleryd IL; Sääf M; Melin AL; Thorén M
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2013-9. PubMed ID: 10372703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide as primary therapy for acromegaly.
    Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in serum GH and IGF-I levels and the GH response to dynamic tests in patients with acromegaly.
    Tanaka S; Fukuda I; Hizuka N; Takano K
    Endocr J; 2010; 57(6):477-83. PubMed ID: 20203424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender dependence of serum soluble Klotho in acromegaly.
    Sze L; Neidert MC; Bernays RL; Zwimpfer C; Wiesli P; Haile SR; Brändle M; Schmid C
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):869-73. PubMed ID: 24330426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum adiponectin levels in adult growth hormone deficiency and acromegaly.
    Fukuda I; Hizuka N; Ishikawa Y; Itoh E; Yasumoto K; Murakami Y; Sata A; Tsukada J; Kurimoto M; Okubo Y; Takano K
    Growth Horm IGF Res; 2004 Dec; 14(6):449-54. PubMed ID: 15519253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
    Marzullo P; Di Somma C; Pratt KL; Khosravi J; Diamandis A; Lombardi G; Colao A; Rosenfeld RG
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?
    Costa AC; Rossi A; Martinelli CE; Machado HR; Moreira AC
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3142-7. PubMed ID: 12107214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group.
    Dall R; Longobardi S; Ehrnborg C; Keay N; Rosén T; Jørgensen JO; Cuneo RC; Boroujerdi MA; Cittadini A; Napoli R; Christiansen JS; Bengtsson BA; Sacca L; Baxter RC; Basset EE; Sönksen PH
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4193-200. PubMed ID: 11095453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
    Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
    Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seeking the optimal target range for insulin-like growth factor I during the treatment of adult growth hormone disorders.
    Mukherjee A; Monson JP; Jönsson PJ; Trainer PJ; Shalet SM;
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5865-70. PubMed ID: 14671182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly.
    Serri O; Beauregard C; Hardy J
    J Clin Endocrinol Metab; 2004 Feb; 89(2):658-61. PubMed ID: 14764777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
    Freda PU; Post KD; Powell JS; Wardlaw SL
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum IGF-I measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population.
    Granada ML; Ulied A; Casanueva FF; Pico A; Lucas T; Torres E; Sanmartí A
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):942-50. PubMed ID: 17980002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly.
    Colao A; Cuocolo A; Marzullo P; Nicolai E; Ferone D; Florimonte L; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1999 Jan; 84(1):17-23. PubMed ID: 9920056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The growth hormone/insulin-like growth factor-I axis hormones and bone markers in elite athletes in response to a maximum exercise test.
    Ehrnborg C; Lange KH; Dall R; Christiansen JS; Lundberg PA; Baxter RC; Boroujerdi MA; Bengtsson BA; Healey ML; Pentecost C; Longobardi S; Napoli R; Rosén T;
    J Clin Endocrinol Metab; 2003 Jan; 88(1):394-401. PubMed ID: 12519882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.